EGFR(S) inhibitors in the treatment of gastro-intestinal cancers: what's new?
Kanwar
Shailender Singh
SS
Veterans Affairs Medical Center, Wayne State University, Detroit, MI 48201, USA.
Nautiyal
Jyoti
J
Majumdar
Adhip P N
AP
D000818:Animals; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology; D066246:ErbB Receptors / Q000037:antagonists & inhibitors* / Q000502:physiology; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology / Q000517:prevention & control; D006801:Humans; D047428:Protein Kinase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use
D047428:Protein Kinase Inhibitors; D066246:ErbB Receptors